The decrease in miR-221 and miR-222 observed in AML is in agreement with functional evidence describing reduced c-KIT–mediated signaling and disruption of cell-cycle regulation upon their downregulation [19,21,29]. The gene discussed is KIT; the disease is acute myeloid leukemia.